基本信息
views: 275

Bio
American Society of Clinical Oncology, American 。Association for Cancer Research。 American Society of Gene and Cell Therapy。 대한암학회, 한국유전자세포치료학회。
publication:
Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy. Joo-Hang Kim, Young-Sook Lee, Hoguen Kim, Jing-Hwa Hwang, A-Rum Yoon, Chae-Ok Yun. Journal of the National Cancer Institute 98:1-12, 2006。
Phase II study of Erlotinib in advanced non-small-cell lung cancer after failure of Gefitinib. Byoung Chul Cho, Chong-Kun Lim, Moo-Suk Park, Se Kyu Kim, Joon Chang, Jong Pil Park, Hye Jin Choi, Yu Jin Kim, Sang-Joon Shin, Joo Hyuk Sohn, Hoguen Kim, Joo Hang Kim. Journal of Clinical Oncology 25:2528-2533, 2007 。
A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results. Choi HJ, Sohn JH, Lee CG, Shim HS, Lee IJ, Yang WI, Kwon JE, Kim SK, Park MS, Lee JH, Kim JH. Lung Cancer. 71: 55-59, 2011。
Research Interests
Papers共 329 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jaemin Choi, Dahye Min,Kali Rigby,Eun-Tae Yun,Jaesung Kim, Yae-Eun Kim,Yong-Yoon Ahn,Yunho Lee,Changha Lee, Eun-Ju Kim,Pedro J. J. Alvarez,Jae-Hong Kim,Jaesang Lee
ACS ES&T ENGINEERING (2025)
NATURE COMMUNICATIONSno. 1 (2025)
Xuanhao Wu, Xiaoxiong Wang,Yunshuo Wu,Huimin Xu, Zhe Li, Rongrong Hong,Kali Rigby,Zhongbiao Wu,Jae-Hong Kim
Nature Communicationsno. 1 (2025): 1-12
Jinling Fan, Leslie K. Arrazolo, Jiaxin Du,Huimin Xu, Siyu Fang,Yue Liu,Zhongbiao Wu,Jae-Hong Kim,Xuanhao Wu
ACS sensorsno. 9 (2024): 4536-4554
ACS NANOno. 14 (2024): 10302-10311
ADVANCED MATERIALSno. 19 (2024)
Environmental Science & Technology (2024)
Load More
Author Statistics
#Papers: 345
#Citation: 19899
H-Index: 69
G-Index: 136
Sociability: 7
Diversity: 3
Activity: 125
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn